Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -324,289 | -211,561 | -109,270 | -376,742 | -286,388 |
| Depreciation Amortization | 3,926 | 2,599 | 1,679 | -840 | -1,643 |
| Accounts payable and accrued liabilities | 4,846 | 6,435 | 3,793 | 1,807 | 2,357 |
| Other Working Capital | -21,936 | -20,142 | -25,083 | -102,827 | -84,678 |
| Other Operating Activity | 75,640 | 42,335 | 24,997 | 131,356 | 99,471 |
| Operating Cash Flow | $-261,813 | $-180,334 | $-103,884 | $-347,246 | $-270,881 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,212 | -6,201 | -3,065 | -8,946 | -5,976 |
| Net Acquisitions | -78 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -848,754 | -673,111 | -339,169 | -486,439 | -486,439 |
| Sale Of Investment | 630,199 | 383,812 | 217,145 | 680,392 | 551,142 |
| Investing Cash Flow | $-229,845 | $-295,500 | $-125,089 | $185,007 | $58,727 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 476,163 | 474,488 | 473,379 | 8,221 | 4,777 |
| Other Financing Activity | 0 | 0 | 0 | -485 | -485 |
| Financing Cash Flow | $476,163 | $474,488 | $473,379 | $7,736 | $4,292 |
| Beginning Cash Position | 290,111 | 290,111 | 290,111 | 444,614 | 444,614 |
| End Cash Position | 274,616 | 288,765 | 534,517 | 290,111 | 236,752 |
| Net Cash Flow | $-15,495 | $-1,346 | $244,406 | $-154,503 | $-207,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | -261,813 | -180,334 | -103,884 | -347,246 | -270,881 |
| Capital Expenditure | -11,212 | -6,201 | -3,065 | -8,946 | -5,976 |
| Free Cash Flow | -273,025 | -186,535 | -106,949 | -356,192 | -276,857 |